Skip to main content

UM SOM Launches Unprecedented Initiatives to Create New Generation of Research Scientists Among Students, Trainees and Faculty

October 04, 2016

James B. Kaper, PhD

New and Expanded Research Development Programs at the University of Maryland School of Medicine will Include Focus on Developing Junior, Minority and Female Faculty Investigators as well as Students and Trainees

James B. Kaper, PhD, Senior Associate Dean for Academic Affairs at the University of Maryland School of Medicine (UM SOM), and Chairman of the UM SOM Department of Microbiology and Immunology, along with UM SOM Dean E. Albert Reece, MD, PhD, MBA, have announced a broad slate of new appointments and programs designed to develop special innovative research expertise among students, trainees and junior faculty at the School of Medicine.

New appointments include senior members of the Dean’s Office who will be dedicated to special Research Development Programs: Wendy Sanders, MA, Assistant Dean for Research Career Development is promoted to Associate Dean; Kerri A. Thom, MD, MS, Associate Professor in the Department of Epidemiology and Public Health has been promoted to Assistant Dean for Student Research and Education; Mary-Claire Roghmann, MD, MS, Professor in the Department of Epidemiology and Public Health, has been promoted to Associate Dean for Physician-Scientist Training, and Trans-disciplinary Research Advancement; and Dudley Strickland, PhD, Professor in the Department of Surgery and Assistant Dean for Graduate Programs in Life Sciences and the Postdoctoral Scholars Program has been promoted to Associate Dean.

The new and expanded roles are designed to further transform and enhance the School of Medicine’s research programs, and specifically help to advance innovation, collaboration and discovery among UM SOM students, trainees and faculty --and with a special emphasis on junior, minority and female faculty – to achieving extraordinary research expertise and accomplishments.

"These four appointments underscore the critical importance of developing effective researchers at every level of our organization,” said Dean Reece, who is also the vice president for Medical Affairs, University of Maryland, and the John Z. and Akiko K. Bowers Distinguished Professor. As the School of Medicine continues to grow significantly as a global biomedical research enterprise, it is imperative that we do everything we can to develop our students, trainees and our faculty into top biomedical scientists and extraordinarily accomplished investigators."

Wendy Sanders, MA

In her new role as Associate Dean for Research Career Development, Ms. Sanders will expand the content of the Research Career Development Program (RCDP), which she conceptualized and founded to provide a wide range of courses, seminars and individual assistance to all faculty and trainees. Specifically, her charge will be to expand the Research Career Development Program, with a Special Group Emphasis on junior, minority and women faculty investigators. In addition, she will focus on developing workshops on scientific leadership and team science, and implementing a faculty research mentoring program.

The RCDP has become one of the most popular and effective programs in the School of Medicine, with more than 1,000 faculty and postdoctoral students participating in courses and programs annually.

Before coming to UM SOM, Sanders served as director of the Professional Development Office at Johns Hopkins University School of Medicine. She earned a BA degree from Oberlin College and an MA degree from the University of Michigan.

Dr. Thom has been appointed Assistant Dean for Student Research and Education and Director of the Office of Student Research (OSR) at UM SOM. She will continue as an Associate Professor in the Department of Epidemiology and Public Health. In her new position, Dr. Thom will oversee the Office of Student Research, which provides SOM students with research education and experience. Specifically, she will be charged with providing all SOM students with exceptional basic, translational and clinical research experiences in biomedical and behavior sciences. In addition, she will facilitate a full understanding of the opportunities in academic medicine as well as enhancing their academic portfolio for future application to competitive residency training programs. Dr. Thom will also develop mentoring programs for students interested in research, and research careers, as well as undergraduate students in order to foster their interest in medicine and other professional fields.

Dr. Kerri A. Thom, MD, MSThom received a BS degree from the University of Florida in zoology, an MD degree from the University of Florida College of Medicine, and an MS degree in Clinical Research from UM SOM. She completed her internal medicine residency, and infectious diseases fellowship at the University of Maryland Medical Center where she served as chief resident. She joined the UM SOM faculty in 2005 as a clinical instructor in medicine, and was promoted to associate professor in 2014.

Dr. Roghmann has been appointed Associate Dean for Physician-Scientist Training, and Trans-disciplinary Research Advancement at UM SOM. She will continue to serve as a Professor in the Department of Epidemiology and Public Health. In her new position, Dr. Roghmann will lead the Medical Scientist Training Program (MD/PhD Program). She will continue to work with the Research Career Development Program, headed by Ms. Sanders, where she will focus on developing training in collaboration and team science. Dr. Roghmann will also foster multiple trans-disciplinary and collaborative groups to forge major research initiatives in order to seek funding from the National Institutes of Health and other federal agencies.

Dr. Mary-Claire Roghmann MD, MSRoghmann received a BS degree in Molecular Genetics from the University of Rochester, an MD degree from Johns Hopkins University School of Medicine, and an MS degree in Epidemiology and Preventive Medicine from the UM SOM. She joined the faculty at UM SOM in 1997. She performed her internship and residency at the University of Maryland Hospital and Baltimore Veterans Administration Hospital, where she was a chief resident as well as a clinical and research fellow in infectious diseases.

Dudley K. Strickland, PhD

Dr. Strickland has been appointed Associate Dean for the Graduate Program in Life Sciences (GPILS), and the Postdoctoral Scholars Program. In this role, he will continue to oversee all aspects of the School of Medicine’s graduate programs in life sciences and postdoctoral programs. In addition, he will extend the new Research Development Programs to all graduate and post-graduate students as well, ensuring that these students are also developed into top collaborative and innovative investigators.

Dr. Strickland, who is also Director of the UM SOM Center for Vascular & Inflammatory Diseases, earned his Ph.D. degree from the University of Kansas in Biochemistry, and completed a postdoctoral fellowship at the University of Notre Dame in the Department of Chemistry. Following his postdoctoral fellowship, Dr. Strickland joined the American Red Cross Research Laboratories in 1982, and was also academically affiliated with The George Washington University. In 1995, he was appointed as Professor in the Department of Biochemistry and Molecular Biology at The George Washington University. In 1997, Dr. Strickland became Head of the Department of Vascular Biology at the American Red Cross.

He then joined the University of Maryland in 2004 as Professor of Surgery and Physiology, and was appointed Director of the Center of Vascular and Inflammatory Diseases in 2005. In 2011, Dr. Strickland was named the Assistant Dean for the GPILS program, and the Post-Doctoral Scholars Program where he has made a transformative impact on our program, especially relative to increasing minority applications and enrollment. He has also made a personal commitment of time and attention to develop personalized strategies to foster success for individual students. He received the UM SOM Diversity and Inclusion Award in 2013.

About the University of Maryland School of Medicine

The University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland’s Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global presence, with research and treatment facilities in more than 35 countries around the world.

Contact

Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories

    Monday, July 01, 2019

    James Kaper Receives Prestigious American Society for Microbiology D.C. White Mentoring Award

    James B. Kaper, PhD, the James and Carolyn Frenkil Distinguished Dean’s Professor Vice Dean for Academic Affairs and Professor and Chairman of the Department of Microbiology & Immunology at the University of Maryland School of Medicine (UMSOM), received the 2019 American Society of Microbiology (ASM) D.C. White Award for his accomplishments in interdisciplinary research and mentoring in microbiology.


    Wednesday, January 16, 2019

    James B. Kaper, PhD, Endowed as James and Carolyn Frenkil Distinguished Dean's Professor

    James B. Kaper, PhD, Professor and Chair of the Department of Microbiology & Immunology and Vice Dean for Academic Affairs, was invested as the James & Carolyn Frenkil Distinguished Dean’s Professor on January 10 before a packed audience at Westminster Hall. Surrounded by family, friends, past and present colleagues and distinguished scientists, Dr. Kaper joined the elite group of 82 SOM faculty who currently hold endowed professorships, the highest honor bestowed by the SOM on individual faculty members.


    Friday, November 30, 2018

    UM School of Medicine Announces Major Management Restructuring and Promotions, as Part of School-Wide Cultural Transformation Initiative

    University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, announced today that, as part of a new school-wide “Program in Cultural Transformation,” the University of Maryland School of Medicine (UMSOM) will launch a major restructuring of its senior leadership positions to ensure that women are represented at the highest levels of the UMSOM.


    Tuesday, July 31, 2018

    University of Maryland School of Medicine Establishes Two Endowed Professorships Through Private Gifts and Matching State Funds

    University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that the school has been awarded matching funds from the Maryland E-Nnovation Initiative Fund (MEIF), administered by the Maryland Department of Commerce. The funds, when combined with private philanthropy, will enable UMSOM to establish two new endowed professorships – one in Microbiology and Immunology, and one in Pharmacology.


    Wednesday, November 01, 2017

    University of Maryland School of Medicine Researchers to Study Spread of Bacteria in Nursing Homes

    Nursing homes are settings with a high prevalence of Staphylococcus aureus (Staph) bacteria, leading to infection and sometimes death in patients. This is a key concern, particularly as there is a growing number of bacteria that are resistant to antibiotics such as methicillin-resistant S. aureus (MRSA), making it difficult to treat infections. The current standard of care for preventing the spread of Staph in nursing homes in the U.S. is for healthcare workers to use gowns and gloves when there is expected contact with blood and other bodily fluids. Researchers at the University of Maryland School of Medicine (UM SOM) will study whether a targeted increase in the use of gowns and gloves is effective in preventing and controlling spread of the dangerous bacteria.


    Tuesday, April 04, 2017

    University of Maryland School of Medicine Physician Scientist Receives Top Award in Epidemiology from Physician's Group

    Mary-Claire Roghmann, MD, MS, Professor of Epidemiology and Public Health, and Associate Dean for Physician Scientist Training and Transdisciplinary Research Advancement, at the University of Maryland School of Medicine (UM SOM), as well an Associate Hospital Epidemiologist and Investigator at the VA Maryland Health Care System, has been awarded the Alvan R. Feinstein Memorial Award from the American College of Physicians (ACP). The award was presented in San Diego at ACP’s Convocation Ceremony on March 30, 2017, during its annual scientific conference, Internal Medicine Meeting 2017.


    Tuesday, January 17, 2017

    Special Issue of Pathogens and Disease Highlights Innovative Research by Scientists at the University of Maryland School of Medicine in Collaboration with UM School of Dentistry

    New research by scientists at the University of Maryland School of Medicine (UM SOM) and the University of Maryland School of Dentistry (UM SOD), is highlighted in a special issue of Pathogens and Disease.


    Friday, June 10, 2016

    FDA Approves Vaccine for Cholera Invented and Developed at University of Maryland School of Medicine

    In a milestone that was years in the making, a vaccine to prevent cholera, invented and developed by researchers at the University of Maryland School of Medicine’s Center for Vaccine Development, was approved today by the U.S. Food and Drug Administration (FDA).